6 Reasons to Invest in Medicure

Medicure is a value-based pharmaceutical company committed to the development and commercialization of innovative and affordable therapeutics for the U.S. market.

Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.

Learn More

Our mission is to serve patients by delivering safe and efficacious life-changing medicines.

At Medicure, we are focused on improving the health of patients by offering a growing portfolio of products and services and ensuring all patients get access to care they need.

Our Products

Press Releases

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED MARCH 31, 2023

May 26, 2023

MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2022

April 6, 2023

MEDICURE TO PRESENT FINANCIAL RESULTS ON APRIL 10, 2023 CALL at 8:30 AM ET FOR QUARTER AND YEAR ENDED DECEMBER 31, 2022

April 5, 2023

More Press Releases

Interview on Medicure's 25th Anniversary with CEO, Dr. Albert Friesen

Read More
2023 Financial Results Announcement for Q1

Medicure announces financial results for quarter ended March 31, 2023 and upcoming conference call.

Learn More
Our Mission

A Heart For Life

At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines

Learn More
Medicure Launches E-Commerce Pharmacy Platform Through its Subsidiary Marley Drug Pharmacy

Medicure Inc.– via Marley Drug, creates a direct-to-consumer e-commerce pharmacy solution. The service is available in all 50 states and can fulfill a formulary of over 100 prescription medications.

Learn More
Research and Products

Phase 3 clinical trial evaluating MC-1 for treatment of pyridoxal 5'-phosphate-dependent epilepsy

Medicure has filed with the FDA an IND for the use of MC-1 as a novel treatment for seizures associated with pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency.

Learn More
Lipid management is important for heart health

At Medicure, we are focused on improving the heart health of patients by delivering safe and efficacious cardiovascular medicines and ensuring all patients get access to therapy.

Learn More
News and Media

Antiplatelet therapy in the management of stroke patients

Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial in Patients with Aneurysmal Subarachnoid Hemorrhage

Learn More